During the past decade, Ireland Cancer Center Landerbrook Health Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 12 clinical trials were completed, i.e. on average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 10 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ireland Cancer Center Landerbrook Health Center" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "Bayer" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ireland Cancer Center Landerbrook Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ireland Cancer Center Landerbrook Health Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "ATM Gene Mutation" (1 trials), "ATR Gene Mutation" (1 trials) and "Adenocarcinoma of the Prostate" (1 trials). Many other conditions were trialed in "Ireland Cancer Center Landerbrook Health Center" in a lesser frequency.

Most popular intervention types in "Ireland Cancer Center Landerbrook Health Center" are "Drug" (12 trials), "Other" (9 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Docetaxel" (4 trials), "Durvalumab" (3 trials), "FGFR Inhibitor AZD4547" (2 trials) and "Ipilimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ireland Cancer Center Landerbrook Health Center" are 11 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ireland Cancer Center Landerbrook Health Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ireland Cancer Center Landerbrook Health Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ireland Cancer Center Landerbrook Health Center, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".